Stock Earnings

Question 1

How did SABS's recent EPS compare to expectations?

Accepted Answer

The most recent EPS for SAB Biotherapeutics Inc is $-0.15, not beating expectations of $-0.51.

Question 2

How did SAB Biotherapeutics Inc SABS's revenue perform in the last quarter?

Accepted Answer

SAB Biotherapeutics Inc revenue for the last quarter is $-0.15

Question 3

What is the revenue estimate for SAB Biotherapeutics Inc?

Accepted Answer

According to 7 of Wall street analyst, the revenue estimate of SAB Biotherapeutics Inc range from $0.0 to $0.0

Question 4

What's the earning quality score for SAB Biotherapeutics Inc?

Accepted Answer

SAB Biotherapeutics Inc has a earning quality score of B+/54.652122. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.

Question 5

When does SAB Biotherapeutics Inc report earnings?

Accepted Answer

SAB Biotherapeutics Inc next earnings report is expected in 2026-02-12

Question 6

What are SAB Biotherapeutics Inc's expected earnings?

Accepted Answer

SAB Biotherapeutics Inc expected earnings is $102.0K, according to wall-street analysts.

Question 7

Did SAB Biotherapeutics Inc beat earnings expectations?

Accepted Answer

SAB Biotherapeutics Inc recent earnings of $0.0 does not beat expectations.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$-0.51	$-0.15	-70.58%	MISSED
Q2 '25	$-0.81	$-1.09	+34.56%	BEAT
Q1 '25	$-1.05	$-0.56	-46.66%	MISSED
Q4 '24	$-1.18	$-1.22	+3.38%	BEAT
Q3 '24	$-1.11	$-1.12	+0.9%	BEAT

SAB Biotherapeutics Inc (SABS) Price

SABS Stock Price Chart

Latest Earnings Results: Q3 '25

Historical Earnings

Earnings FAQ